{
    "2021-04-20": [
        [
            {
                "time": "2021-04-20",
                "original_text": "智飞生物（300122）2020年年报及2021年一季报点评：业绩超市场预期，新冠疫苗业绩兑现【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "一季报",
                        "新冠疫苗",
                        "业绩超预期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "太平洋 - 智飞生物：新冠疫苗放量在即，自研产品进入收获期【公司研究】",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "自研产品",
                        "放量在即"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "一季度多只医药股获明星基金增持",
                "features": {
                    "keywords": [
                        "医药股",
                        "明星基金",
                        "增持"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "山西证券：医药行业基本面良好，刚需带来确定性成长",
                "features": {
                    "keywords": [
                        "医药行业",
                        "基本面",
                        "刚需",
                        "成长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "华西证券：智飞生物（300122.SZ）2021Q1业绩超预期，维持“买入”评级",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2021Q1",
                        "业绩超预期",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "最新！傅鹏博、谢治宇、朱少醒、邓晓峰持股变动名单",
                "features": {
                    "keywords": [
                        "傅鹏博",
                        "谢治宇",
                        "朱少醒",
                        "邓晓峰",
                        "持股变动"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "平安证券 - 生物医药行业周报：第五批药品国采数据流出，集采成为常态符合预期【行业研究】",
                "features": {
                    "keywords": [
                        "生物医药",
                        "第五批药品国采",
                        "集采",
                        "常态"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}